NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Change in Receivables (2020 - 2026)

Updated

NRX Pharmaceuticals (NRXP) reported Change in Receivables of $50,000 for Q2 2026, up 4.2% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Change in Receivables (2020 - 2026) Analysis & Trends

For FY2025, NRX Pharmaceuticals posted Change in Receivables of -$48,000.

  • By year, Change in Receivables came in at -$831,000 in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly Change in Receivables since Q3 2020.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $48,000 (Q1 2026), -$36,000 (Q4 2025) and -$12,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00 50,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50,000.00
Mar 31, 2026 48,000.00
Dec 31, 2025 -36,000.00
Sep 30, 2025 -12,000.00
Mar 31, 2021 -831,000.00
Dec 31, 2020 -423,090.00
Sep 30, 2020 939,868.00
API Access

NRX Pharmaceuticals Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=NRXP&period=max&api_key=YOUR_API_KEY